Literature DB >> 17142352

Molecular and functional properties of lung SP cells.

Susan D Reynolds1, Hongmei Shen, Paul R Reynolds, Tomoko Betsuyaku, Joseph M Pilewski, Federica Gambelli, Michelangelo Di Giuseppe, Michelangelo DeGuiseppe, Luis A Ortiz, Barry R Stripp.   

Abstract

Previous analysis of lung injury and repair has provided evidence for region-specific stem cells that maintain proximal and distal epithelial compartments. However, redundant expression of lineage markers by cells at several levels of the stem cell hierarchy has complicated phenotypic and functional characterization of clonogenic airway cells. Based on the demonstration that rapid efflux of the DNA dye Hoechst 33342 can be used to prospectively purify long-term repopulating hematopoietic stem cells, we hypothesized that lung cells with similar biochemical properties would be enriched for clonogenic progenitors. We demonstrate that Hoechst-dim side population (SP) cells isolated from proximal and distal compartments of the mouse lung were relatively small and agranular, exhibited low red and green autofluorescence, and that the SP fraction was highly enriched in clonogenic cells. Quantitative RT-PCR indicated that vimentin mRNA was enriched and that epithelial markers were depleted in these preparations of SP cells. Bleomycin exposure was associated with decreased clonogenicity among alveolar SP and suggested that SP cell function was compromised under profibrotic conditions. We conclude that the SP phenotype is common to clonogenic cells at multiple airway locations and suggest that Hoechst efflux is a property of cells expressing a wound-repair phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142352     DOI: 10.1152/ajplung.00090.2006

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  26 in total

1.  Conditional stabilization of beta-catenin expands the pool of lung stem cells.

Authors:  Susan D Reynolds; Anna C Zemke; Adam Giangreco; Brian L Brockway; Roxana M Teisanu; Jeffrey A Drake; Thomas Mariani; Peter Y P Di; Mark M Taketo; Barry R Stripp
Journal:  Stem Cells       Date:  2008-03-20       Impact factor: 6.277

Review 2.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

3.  Lung epithelial healing: a modified seed and soil concept.

Authors:  Susan D Reynolds; Heather M Brechbuhl; Mary Kathryn Smith; Russell W Smith; Moumita Ghosh
Journal:  Proc Am Thorac Soc       Date:  2012-05

4.  Circulating progenitor cells in chronic lung disease.

Authors:  Borna Mehrad; Michael P Keane; Brigitte N Gomperts; Robert M Strieter
Journal:  Expert Rev Respir Med       Date:  2007-08       Impact factor: 3.772

Review 5.  Bronchiolar progenitor cells.

Authors:  Huaiyong Chen; Keitaro Matsumoto; Barry R Stripp
Journal:  Proc Am Thorac Soc       Date:  2009-12-01

6.  CD24-positive cells from normal adult mouse liver are hepatocyte progenitor cells.

Authors:  Qiong Qiu; Julio Cesar Hernandez; Adam M Dean; Pulivarthi H Rao; Gretchen J Darlington
Journal:  Stem Cells Dev       Date:  2011-10-21       Impact factor: 3.272

Review 7.  Potential role of stem cells in management of COPD.

Authors:  Tillie L Hackett; Darryl A Knight; Don D Sin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

Review 8.  Endogenous lung stem cells and contribution to disease.

Authors:  J C Snyder; R M Teisanu; B R Stripp
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

9.  Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice.

Authors:  Shigehisa Yanagi; Hiroyuki Kishimoto; Kohichi Kawahara; Takehiko Sasaki; Masato Sasaki; Miki Nishio; Nobuyuki Yajima; Koichi Hamada; Yasuo Horie; Hiroshi Kubo; Jeffrey A Whitsett; Tak Wah Mak; Toru Nakano; Masamitsu Nakazato; Akira Suzuki
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

Review 10.  New molecularly targeted therapies for lung cancer.

Authors:  Sophie Sun; Joan H Schiller; Monica Spinola; John D Minna
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.